Clinical TrialsSearch results
Number of results: 1194
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Z-206 Phase III Clinical Trial -Investigation on the remission–maintaining effect in patients with Crohn's disease in remission phase-
- Patients with Crohn's disease in remission phase
- Zeria Pharmaceutical Co.,LTD.
- 2005-12-22
Other
- Z-206 Phase III Clinical Trial - Investigation on the remission-maintaining effect in patients with ulcerative colitis in remission phase -
- Patients with ulcerative colitis in remission phase.
- Zeria Pharmaceutical Co.,LTD.
- 2005-11-21
Other
- Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with ulcerative colitis in active phase -
- Patients with ulcerative colitis in active phase
- Zeria Pharmaceutical Co.,LTD.
- 2005-11-21
Other
- Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phase -
- Patients with Crohn's disease in active phase
- Zeria Pharmaceutical Co.,LTD
- 2005-12-22
Other
- WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancer
- pancreas cancer
- Department of Cancer immunotherapy, Osaka University Medical School
- 2008-06-20
Other
- WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancer
- pancreas cancer
- Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine
- 2008-06-26
Other
- Vitreous concentration of moxfloxacin and bacterial isolation during vitreous surgery
- Vitreoretinal diseases
- Osaka University Hospital, Department of Ophthalmology
- 2009-12-01
Other
- Visceral Fat Accumulation and Coronary Artery Disease Investigation in Japan
- subjects in Ningen Dock, people who recieve routine medical checkups, and coronary artery disease patients
- Osaka University
- 2010-03-31
Other
- Verification of the efficacy of intravaginal ulinastatin administration in patients with cervical shortening
- Pregnant women with subclinical infection and cervical length 25 mm as diagnosed by transvaginal ultrasonography in a maternity health examination conducted during the second trimester of pregnancy (between week 16 day 0 and week 26 day 6 of gestation)
- Japan Organization of Prevention of Preterm Delivery
- 2009-04-15
Other
- Validation study VI of febrile neutropenia guideline 2004
- Febrile Neutropenia
- Japan Febrile Neutropenia Study Group
- 2006-08-04